The EU has formally approved the Pfizer-BioNTech coronavirus vaccine on Monday after it was given the green light as safe by the European Medicines Agency, the bloc’s regulator.
“Based on this scientific assessment, we proceeded to authorise it for the European Union market,” EU chief Ursula von der Leyen said in a video statement.
“As we have promised, this vaccine will be available for EU countries at the same time on the same conditions,” she said, adding that the rollout will begin on December 27.
The EU has formally approved the Pfizer-BioNTech coronavirus vaccine on Monday after it was given the green light as safe by the European Medicines Agency, the bloc’s regulator.
“Based on this scientific assessment, we proceeded to authorise it for the European Union market,” EU chief Ursula von der Leyen said in a video statement.
“As we have promised, this vaccine will be available for EU countries at the same time on the same conditions,” she said, adding that the rollout will begin on December 27.
The EU has formally approved the Pfizer-BioNTech coronavirus vaccine on Monday after it was given the green light as safe by the European Medicines Agency, the bloc’s regulator.
“Based on this scientific assessment, we proceeded to authorise it for the European Union market,” EU chief Ursula von der Leyen said in a video statement.
“As we have promised, this vaccine will be available for EU countries at the same time on the same conditions,” she said, adding that the rollout will begin on December 27.
The EU has formally approved the Pfizer-BioNTech coronavirus vaccine on Monday after it was given the green light as safe by the European Medicines Agency, the bloc’s regulator.
“Based on this scientific assessment, we proceeded to authorise it for the European Union market,” EU chief Ursula von der Leyen said in a video statement.
“As we have promised, this vaccine will be available for EU countries at the same time on the same conditions,” she said, adding that the rollout will begin on December 27.
The EU has formally approved the Pfizer-BioNTech coronavirus vaccine on Monday after it was given the green light as safe by the European Medicines Agency, the bloc’s regulator.
“Based on this scientific assessment, we proceeded to authorise it for the European Union market,” EU chief Ursula von der Leyen said in a video statement.
“As we have promised, this vaccine will be available for EU countries at the same time on the same conditions,” she said, adding that the rollout will begin on December 27.
The EU has formally approved the Pfizer-BioNTech coronavirus vaccine on Monday after it was given the green light as safe by the European Medicines Agency, the bloc’s regulator.
“Based on this scientific assessment, we proceeded to authorise it for the European Union market,” EU chief Ursula von der Leyen said in a video statement.
“As we have promised, this vaccine will be available for EU countries at the same time on the same conditions,” she said, adding that the rollout will begin on December 27.
The EU has formally approved the Pfizer-BioNTech coronavirus vaccine on Monday after it was given the green light as safe by the European Medicines Agency, the bloc’s regulator.
“Based on this scientific assessment, we proceeded to authorise it for the European Union market,” EU chief Ursula von der Leyen said in a video statement.
“As we have promised, this vaccine will be available for EU countries at the same time on the same conditions,” she said, adding that the rollout will begin on December 27.
The EU has formally approved the Pfizer-BioNTech coronavirus vaccine on Monday after it was given the green light as safe by the European Medicines Agency, the bloc’s regulator.
“Based on this scientific assessment, we proceeded to authorise it for the European Union market,” EU chief Ursula von der Leyen said in a video statement.
“As we have promised, this vaccine will be available for EU countries at the same time on the same conditions,” she said, adding that the rollout will begin on December 27.
Related posts:
Canada approves Pfizer/Biontech Covid-19 vaccine
UK approves Pfizer-BioNtech coronavirus vaccine
U.S to pay Pfizer, Biontech $1.95bn for COVID-19 vaccine
US Vice President takes Pfizer/Biontech Covid-19 vaccine
COVID-19: Britain orders additional 35 million vaccine doses from Pfizer-BioNTech
Just In: NAFDAC approves Pfizer COVID-19 vaccine for Nigerians
Covid-19: US approves Pfizer vaccine for 5-11 year olds
Covid-19: South Africa approves Pfizer vaccine for children aged 5-11 years
